Point72 Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $29.7M | Sell |
|
|||||
|
2023
Q2 | $86.7M | Sell |
|
|||||
|
2023
Q1 | $81.4M | Buy |
|
|||||
|
2022
Q4 | $32M | Buy |
|
|||||
|
2022
Q3 | $31.1M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $10.5M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $13.4M | Sell |
|
|||||
|
2021
Q1 | $143M | Buy |
|
|||||
|
2020
Q4 | $52.7M | Buy |
|
|||||
|
2020
Q3 | $35.4M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $25.1M | Sell |
|
|||||
|
2019
Q3 | $33.1M | Buy |
|
|||||
|
2019
Q2 | $21.5M | Buy |
|
|||||
|
2019
Q1 | $20.4M | Buy |
|
|||||
|
2018
Q4 | $11.3M | Sell |
|
|||||
|
2018
Q3 | $19.8M | Sell |
|
|||||
|
2018
Q2 | $58.6M | Buy |
|
|||||
|
2018
Q1 | $4.89M | Sell |
|
|||||
|
2017
Q4 | $106M | Sell |
|
|||||
|
2017
Q3 | $138M | Buy |
|
|||||
|
2017
Q2 | $1.44M | Sell |
|
|||||
|
2017
Q1 | $29.7M | Sell |
|
|||||
|
2016
Q4 | $65.3M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $66.7M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1.56M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $3.44M | Buy |
|
|||||
|
2014
Q4 | $1.96M | Sell |
|
|||||
|
2014
Q3 | $49.8M | Sell |
|
|||||
|
2014
Q2 | $88.5M | Buy |
|